• TABRECTA is used to treat adults with NSCLC that:

  • has spread to other parts of the body (metastatic), and

  • whose tumors have an abnormality in their mesenchymal-epithelial transition (MET) gene. Your health care provider will perform a test to make sure that TABRECTA is right for you

It is not known if TABRECTA is safe and effective in children.

• TABRECTA works by blocking the activity of proteins made by MET exon 14 skipping that can cause your cancer to grow

  • TABRECTA affects both cancer cells and healthy cells

  • Although TABRECTA has been studied in people with NSCLC, how TABRECTA works has been demonstrated only in laboratory studies